De-escalation of antimicrobial treatment for adults with sepsis, severe sepsis or septic shock

Cochrane Database of Systematic Reviews

Volumn , Issue 3, 2009, Pages

  Gomes Silva, Brenda Nazaré ^a   Andriolo, Régis B ^b   Atallah, Álvaro N ^b   Salomão, Reinaldo ^b  

^a Brazilian Cochrane Centre   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA EXTRACTION; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG SAFETY; HOSPITALIZATION; HUMAN; INFORMATION PROCESSING; INTENSIVE CARE UNIT; INTERVENTION STUDY; LIVER TOXICITY; MEDICAL ERROR; MORTALITY; NEPHROTOXICITY; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SEPSIS; SEPTIC SHOCK; TREATMENT OUTCOME;

EID: 70049115940     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007934     Document Type: Review

References (34)

1. American Thoracic Society, Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. American Journal Respiratory and Critical Care Medicine 2005;171(4):388-416. [PUBMED: 15699079]
2. Bone RC, Sprung CL, Sibbald WJ. Definitions for sepsis and organ failure. critical care medicine 1992;20(6):724-726 [PUBMED: 1600757]
3. Cheng B, Xie G, Yao S, Wu X, Guo Q, Gu M, et al.Epidemiology of severe sepsis in critically ill surgical patients in ten university hospitals in China. Critical Care Medicine 2007;35(11):2538-2546 [PUBMED: 17828034] (Pubitemid 351339014)
4. Darby JM, Linden P, Pasculle W, Saul M. Utilization and diagnostic yield of blood cultures in a surgical intensive care unit. Critical Care Medicine 1997;25(6):989-994 [PUBMED: 9201052] (Pubitemid 27264244)
5. de Jonge E, Schultz MJ, Spanjaard L, Bossuyt PM, Vroom MB, Dankert J, et al.Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial. Lancet 2003;362(9389):1011-1016 [PUBMED: 14522530] (Pubitemid 37186877)
6. Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al.Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Medicine 2008;34(1):16-60. [PUBMED: 18058085]
7. Dombrovskiy VY, Martin AA, Sunderram J, Paz HL. Rapid increase in hospitalization and mortality rates for severe sepsis in the United States: a trend analysis from 1993 to 2003. Critical Care Medicine 2007;35(5):1244-1250 [PUBMED: 17414736]
8. Dougnac AL, Mercado MF, Cornejo RR, Cariaga MV, Hernández GP, Andresen MH, et al.Prevalence of severe sepsis in intensive care units. A national multicentric study [Prevalencia de sepsis grave en las Unidades de Cuidado Intensivo. Primer estudio nacional multicéntrico]. Revista Médica de Chile 2007;135(5):620-630 [PUBMED: 17657331]
9. Garnacho-Montero J, Garcia-Garmendia JL, Barrero-Almodovar A, Jimenez-Jimenez FJ, Perez-Paredes C, Ortiz-Leyba C. Impact of adequate empiric antibiotic therapy on the outcome of patients admitted to the intensive care unit with sepsis. Critical Care Medicine 2003;31(12):2742-2751 [PUBMED: 14668610] (Pubitemid 38010630)
10. Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clinical Infectious Diseases 2003;37(1):59-64. [PUBMED: 12830409] (Pubitemid 36836645)
11. Harbarth S, Garbino J, Pugin J, Romand JA, Lew D, Pittet D. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. American Journal of Medicine 2003;115(7):529-535 [PUBMED: 14599631 ] (Pubitemid 37352798)
12. Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics in Medicine 2002. [PUBMED: 12111919]
13. Höffken G, Niederman MS. Nosocomial pneumonia: The importance of a de-escalating strategy for antibiotic treatment of pneumonia in the ICU. Chest 2002;122:2183-2196 [PUBMED: 12475862 ] (Pubitemid 36051158)
14. Infectious Diseases Society of America. Bad bugs, no drugs. As antibiotic discovery stagnates . . . a public health crisis brews. http://www.idsociety. org/badbugsnodrugs.html. Alexandria: Infectious Diseases Society of America, 2004.
15. Iñigo J, Sendra JM, Díaz R, Bouza C, Sarría-Santamera A. Epidemiology and costs of severe sepsis in Madrid. A hospital discharge study [Epidemiología y costes de la sepsis grave en Madrid.Estudio de altas hospitalarias]. Medicina Intensiva 2006;30(5):197-203. [PUBMED: 16938192]
16. Kollef MH. Hospital-acquired pneumonia and de-escalation of antimicrobial treatment. Critical Care Medicine 2001;29(7):1473-1475 [PUBMED: 11445712]
17. Kollef MH. Providing appropriate antimicrobial therapy in the intensive care unit: surveillance vs. de-escalation. Critical Care Medicine 2006;34(3):903-905 [PUBMED: 16505677]
18. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al.Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Critical Care Medicine 2006;34(6):1589-1596 [PUBMED: 16625125] (Pubitemid 43810035)
19. Latour J, Abraira V, Cabello JB, López Sánchez J. Investigation methods in clinical cardiology. IV. Clinical measurements incardiology: validity and errors of measurements [Las mediciones clínicas en cardiología: validez y errores de medición]. Revista Española de Cardiología 1997;50(2):117-128 [PUBMED: 9091999 ]
20. Leone M, Garcin F, Bouvenot J, Boyadjev I, Visintini, Albanèse J, et al.Ventilator-associated pneumonia: Breaking the vicious circle of antibiotic overuse. Critical Care Medicine 2007;35(2):379-385 [PUBMED: 17205011] (Pubitemid 46148525)
21. Leone M, Martin C. How to break the vicious circle of antibiotic resistances?. Current Opinion in Critical Care 2008;14(5):587-592 [PUBMED: 18787454 ]
22. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Medicine 2003;29(4):530-538 [PUBMED: 12664219] (Pubitemid 36523666)
23. MacArthur RD, Miller M, Albertson T, Panacek E, Johnson D, Teoh L, Barchuk W. Adequacy of early empiric antibiotic treatment and survival in severe sepsis: experience from the MONARCS trial. Clinical Infectious Diseases 2004;38(2):284-288 [PUBMED: 14699463] (Pubitemid 38113039)
24. Micek ST, Lloyd AE, Ritchie DJ, Reichley RM, Fraser VJ, Kollef MH. Pseudomonas aeruginosa bloodstream infection: importance of appropriate initial antimicrobial treatment. Antimicrobial Agents Chemotherapy 2005;49(4):1306-1311 [PUBMED: 15793102]
25. Niederman MS. De-escalation therapy in ventilator-associated pneumonia. Current Opinion in Critical Care 2006;12(5):425-427 [PUBMED: 16943725 ]
26. Paul M, Silbiger I, Grozinsky S, Soares-Weiser K, Leibovici L. Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis. Cochrane Database of Systematic Reviews 2006, Issue 1. [DOI: 10.1002/14651858]
27. Proulx N, Fréchette D, Toye B, Chan J, Kravcik S. Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. Quarterly Journal of Medicine: monthly journal of the Association of Physicians 2005;98(4):291-298 [PUBMED: 15760921] (Pubitemid 40500689)
28. Rello J, Vidaur L, Sandiumenge A, Rodríguez A, Gualis B, Boque C, et al.De-escalation therapy in ventilator-associated pneumonia. Critical Care Medicine 2004;32(11):2183-2190 [PUBMED: 15640629]
29. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.0. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2008.
30. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al.Brazilian Sepsis Epidemiological Study (BASES study). Critical Care 2004;8(4):R251-60. [PUBMED: 15312226]
31. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American journal of respiratory and critical care medicine 2000;162(2 Pt1):505-511 [PUBMED: 10934078] (Pubitemid 30647191)
32. Teles JMM, Silva E, Westphal G, Filho RC, Machado FR. Surviving sepsis campaign in Brazil. Shock 2008;30(7):1-6. [PUBMED: 18704009]
33. Vallés J, Rello J, Ochagavía A, Garnacho J, AlcaláMA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 2003;125(5):1615-1624 [PUBMED: 12740282] (Pubitemid 36549784)
34. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al.Sepsis in European intensive care units: results of the SOAP study. Critical Care Medicine 2006;34(2):344-353 [PUBMED: 16424713] (Pubitemid 43145611)